ZACHARY SMITH: Open Payments
NPI 1962754754 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 49 payments from 13 companies in 2025. Trend: 2023 $495 · 2024 $1,842 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $261 |
| Otsuka America Pharmaceutical, Inc. | 9 | $142 |
| Lundbeck LLC | 6 | $122 |
| Axsome Therapeutics, Inc. | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| ABBVIE INC. | 4 | $70 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| Alkermes, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
Products named: REXULTI, HETLIOZ, FANAPT, Auvelity, TRINTELLIX, CAPLYTA, VRAYLAR, INGREZZA.
Industry payments across OH — which companies pay providers there.
